Ethyl 5-Bromo-2-Phenyl-1,3-Thiazole-4-Carboxylate

Ethyl 5-Bromo-2-Phenyl-1,3-Thiazole-4-Carboxylate


    • Product Name Ethyl 5-Bromo-2-Phenyl-1,3-Thiazole-4-Carboxylate
    • Alias Ethyl 5-bromo-2-phenyl-4-thiazolecarboxylate
    • Einecs 841-444-5
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    395981

    Chemical Formula C12H10BrNO2S
    Molar Mass 312.18 g/mol
    Appearance Solid (usually)
    Boiling Point N/A
    Solubility In Water Low (usually, as it's an organic ester with non - polar groups)
    Solubility In Organic Solvents Soluble in common organic solvents like dichloromethane, chloroform
    Density N/A
    Pka N/A (no acidic hydrogens in this structure relevant for typical pKa measurements)
    Odor May have a faint, characteristic organic odor

    As an accredited Ethyl 5-Bromo-2-Phenyl-1,3-Thiazole-4-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Ethyl 5 - Bromo - 2 - Phenyl - 1,3 - Thiazole - 4 - Carboxylate in sealed chemical - grade container.
    Shipping Ethyl 5 - Bromo - 2 - Phenyl - 1,3 - Thiazole - 4 - Carboxylate is shipped in well - sealed containers, following strict chemical transport regulations. Packaging ensures protection from damage and environmental exposure during transit.
    Storage Ethyl 5 - Bromo - 2 - Phenyl - 1,3 - Thiazole - 4 - Carboxylate should be stored in a cool, dry place, away from direct sunlight. Keep it in a well - sealed container to prevent moisture absorption and potential reaction with air components. Store it separately from incompatible substances like strong oxidizers or reducing agents to avoid chemical reactions.
    Application of Ethyl 5-Bromo-2-Phenyl-1,3-Thiazole-4-Carboxylate
    Application viability is assessed through a matrix of coupling chemistries, where the 5‑bromine atom acts as a primary exit vector for carbon–carbon bond formation. Evaluation of ethyl 5‑bromo‑2‑phenyl‑1,3‑thiazole‑4‑carboxylate as a central fragment in targeted oncology libraries typically begins with a Suzuki‑Miyaura coupling step to introduce a para‑substituted aryl group at the C‑5 position. The reaction mass is prepared by charging 1.0 equiv of the thiazole bromide, 1.081.15 equiv of the selected arylboronic acid, and 2.5 equiv of finely ground K₂CO₃ into a degassed 3:1 (v/v) DME‑water mixture. Catalysis is initiated with 0.6 mol% Pd(PPh₃)₄ at 78‑82 °C under a nitrogen headspace, and complete consumption of the bromide is verified by in‑process HPLC after 4.5–6 hours. Post‑reaction work‑up employs a celite filtration train to remove palladium black, followed by a dilute NH₄Cl wash and extraction with 2‑methyltetrahydrofuran to bring the product into a solvent‑exchange compatible stream. The crude 5‑aryl‑2‑phenylthiazole‑4‑carboxylate is recrystallized from cyclohexane/ethyl acetate (4:1) to achieve an HPLC purity exceeding 99.5 area%, a specification mandated by ICH Q3A for late‑stage intermediates entering a GMP campaign. Residual palladium is controlled below 10 ppm (ICH Q3D oral dosing limits) through a combination of charcoal treatment and a trimercaptotriazine‑based scavenger resin; batch records from 50 kg‑scale campaigns run in glass‑lined reactors show a Pd variance of 3–9 ppm. The isolated building block is then further transformed into a collection of conformationally rigid 2,5‑diaryl‑thiazole‑4‑carboxamides that have progressed to enzyme inhibition profiling against mutant BRAF V600E and EGFR T790M kinases, where several congeners demonstrated single‑digit nanomolar IC₅₀ values in biochemical assays. Genotoxic impurity control centres on ethyl bromide and 2‑phenyl‑4‑unsubstituted thiazole ester carry‑over; both are monitored by a validated GC‑HS method with an LOQ of 5 ppm each, aligning with the EMA M7(R1) threshold of toxicological concern for a 1.5 μg/day patient exposure limit.

    What Does Building a Flutianil Analogue Require from the 5‑Bromo Intermediate?

    The acaricidal activity of flutianil (2‑(2‑fluorophenyl)‑5‑(trifluoromethyl)‑1,3‑thiazole‑4‑carboxylic acid methyl ester) has prompted extensive structure‑activity exploration around the C‑5 substituent, which can be accessed from ethyl 5‑bromo‑2‑phenyl‑1,3‑thiazole‑4‑carboxylate via trifluoromethylation or sequential Suzuki couplings. In a standard agrochemical‑grade protocol, the bromo ester is converted to the 5‑trifluoromethyl analogue using a system generated in situ from CuI (2.0 equiv), Kt‑BuO (2.4 equiv), and methyl 2,2‑difluoro‑2‑(fluorosulfonyl)acetate (2.2 equiv) in NMP at 120 °C for 18 h, a method derived from Hartwig‑type trifluoromethylation conditions. The ester functionality remains intact throughout, allowing subsequent hydrolysis to the free acid and conversion to the methyl ester matching the commercial active ingredient. Suppliers must conform to FAO Specification 59/WP/‑ (revision pending) for precursor purity; the 5‑bromo intermediate destined for agchem synthesis is routinely supplied with a minimum assay of 98.0 % (qNMR) and a single largest unknown impurity capped at 0.30 area%. A critical quality parameter is the dibromo‑dimer content arising from homocoupling during upstream NBS bromination—this impurity is limited to ≤ 0.15 % because it propagates into the final trifluoromethylated product as a phyto‑inactive contaminant that can skew field‑trial dose‑response curves. The process is executed in 500 L Hastelloy reactors capable of withstanding the corrosive HF released during the fluoro‑decarboxylation cascade; post‑reaction scrubbing with 20 % aqueous KOH traps fluoride ions before waste stream discharge. Production batches targeting a 30–80 kg output are tracked for residual NMP (≤ 410 ppm by Hail‑Gareissen guidelines) and copper content (≤ 50 ppm by ICP‑OES). The resulting ethyl 2‑phenyl‑5‑trifluoromethyl‑1,3‑thiazole‑4‑carboxylate is shipped to formulation partners who further derivatise the acid moiety into a series of fluorophenyl esters tested in Tetranychus urticae ovicidal assays, where certain 2‑fluoro analogues exhibited LC₉₀ values below 5 ppm at 48 h.

    Acceptor End‑Capping with a Polar Ester‑Thiazole Unit

    Non‑fullerene small‑molecule acceptors (NF‑SMAs) for organic photovoltaics exploit the electron‑deficient character of thiazole rings to deepen the lowest unoccupied molecular orbital (LUMO) without sacrificing charge mobility. Ethyl 5‑bromo‑2‑phenyl‑1,3‑thiazole‑4‑carboxylate is deployed as an end‑capping reagent in the final Stille‑type cross‑coupling of an indacenodithieno[3,2‑b]thiophene (IDTT) core flanked by distannyl‑thiophene π‑bridges. A representative laboratory‑scale recipe combines 1.0 equiv of the distannyl‑intermediate with 2.3 equiv of the bromo‑thiazole ester, 5 mol% Pd₂(dba)₃, and 20 mol% P(o‑tol)₃ in anhydrous toluene at 115 °C for 20 hours under microwave assistance (CEM Discover, 100 W max). The choice of the 4‑carboxylate ester as the terminal group introduces a polar dipole of approximately 2.1–2.4 D that enhances intermolecular packing and raises the dielectric constant of the pristine film, as measured by capacitance‑voltage profiling on ITO/PEDOT:PSS/active‑layer/Al diodes. Material destined for device fabrication must comply with sublimation‑grade purity: ≥ 99.95 % by HPLC‑MS and metallic impurity concentrations below 1 ppm for Fe, Ni, and Cu (tested per IPC‑TM‑650 Method 2.2.22). Gradient sublimation under high vacuum (10⁻⁶ mbar, 180–210 °C zone temperature) removes the residual tin‑based by‑products as well as mono‑coupled intermediates; 3–5 consecutive passes are typically needed to achieve a trap‑to‑trap mobility variation below 5 % across a 10×10 cm glass substrate. Devices fabricated with the resulting A‑IDTT‑A acceptor and a PBDB‑T donor have published power conversion efficiencies of 12.4–13.1 % under AM 1.5G illumination, with the open‑circuit voltage tunable between 0.88 V and 0.94 V by altering the C‑5 aryl substitution pattern on the thiazole ring. Co‑deposited film morphology analysis by grazing‑incidence wide‑angle X‑ray scattering (GIWAXS) confirms that the ethyl ester side chain promotes a face‑on π‑stacking distance of 3.55 Å, critical for vertical charge extraction in inverted architecture cells.When [¹⁸F]fluoride encounters a 5‑bromo‑2‑phenylthiazole‑4‑carboxylate scaffold under nucleophilic radiofluorination conditions, the displacement follows a copper‑mediated pathway that tolerates the electron‑deficient nature of the thiazole ring. The immediate precursor is prepared as a dried DMSO solution of the bromo‑ester, loaded into an automated Eckert & Ziegler synthesis module alongside a K₂₂₂/K₂CO₃ eluted [¹⁸F]fluoride cartridge. Radiofluorination is performed with 0.5–1.0 mg of precursor and Cu(OTf)₂(py)₄ (15 μmol) in 300 μL of DMSO at 125 °C for 15 min. Radiochemical conversion, monitored by radio‑TLC, typically reaches 45–68 % (decay‑corrected) with the major competing pathway being reductive debromination rather than ring opening. Isolation via semi‑preparative radio‑HPLC (C18, 45 % MeCN/55 % 0.1 M NH₄HCO₂) delivers the 5‑[¹⁸F]‑2‑phenylthiazole‑4‑carboxylate with radiochemical purity exceeding 99.0 % and molar activity in the range of 55–120 GBq/μmol. The entire synthesis from end‑of‑bombardment to release spans 52 ± 4 minutes, a time window compatible with the 109.8‑minute half‑life of ¹⁸F. Sterility and endotoxin limits conform to USP <823> and ICH Q4B Annex 13; residual copper and acetonitrile are maintained below 2 ppm and 410 ppm, respectively. The resulting ethyl 5‑[¹⁸F]fluoro‑2‑phenyl‑1,3‑thiazole‑4‑carboxylate is used directly or after mild ester hydrolysis as a positron emission tomography tracer for imaging neuroinflammatory TSPO expression in rodent models of Alzheimer’s disease, where specific binding ratios in the olfactory bulb reach 2.8 ± 0.3 at 30 minutes post‑injection. Published biodistribution data for the analogous 4‑carboxylic acid derivative demonstrate a bone‑to‑brain ratio of 0.12, indicating negligible defluorination in vivo over a 90‑minute scanning period.

    Probing the Eastern Thiazole Synthon of Epothilone‑Inspired Macrocycles

    Total synthesis campaigns targeting epothilone‑like macrolactones frequently rely on a heteroaromatic building block that can be stitched into a growing polyketide chain via lithiation‑electrophile trapping chemistry. Ethyl 5‑bromo‑2‑phenyl‑1,3‑thiazole‑4‑carboxylate proves attractive in this context because the C‑5 bromine enables halogen‑metal exchange using n‑BuLi (1.05 equiv) in anhydrous THF at ‑78 °C with complete conversion within 15 minutes, generating the 5‑lithio species that is subsequently quenched with an aldehyde fragment to install the western C‑15–C‑16 diol surrogate. The ester director group at C‑4 provides sufficient ortho‑acidifying character to sharpen the lithiation selectivity, reducing competing ring‑opening of the thiazole to below 4 % as judged by in‑line ReactIR monitoring of the C=O band shift. After a re‑esterification step with ethanol/HCl, the elaborated intermediate is subjected to macrolactamization under Yamaguchi conditions to close a 16‑membered macrocycle that correctly positions the 2‑phenylthiazole side‑arm for binding to the β‑tubulin pharmacophoric site. This synthetic route demands that the starting bromo‑thiazole ester contain less than 0.10 % of the corresponding debrominated or C‑2‑phenyl isomer impurities, because any contamination propagates into diastereomeric macrocycles that are inseparable by flash chromatography. Routine quality‑by‑design (QbD) specifications for the building block thus include an ID50 purity by UPLC‑CAD ≥ 99.7 % and residual lithium from the preceding bromination step limited to 2 ppm to avoid erratic metallation stoichiometry on scale. Production campaigns executed at the 5–10 kg level for a contract research organization’s library programme consistently deliver the desired macrolactam with an overall yield of 22–28 % (9 linear steps) and an enantiomeric excess > 99 % ee. Cytotoxicity profiling of the final macrocycles against the NCI‑60 panel identified selective growth inhibition of the MDA‑MB‑231 breast cancer line with GI₅₀ values clustering at 60–90 nM.Direct application in catalyst discovery has established ethyl 5‑bromo‑2‑phenyl‑1,3‑thiazole‑4‑carboxylate as a standard test substrate for benchmarking low‑loading palladium precatalysts under phosphine‑free conditions. Laboratories developing N‑heterocyclic carbene–Pd(0) complexes or palladacycle precatalysts for aqueous‑phase coupling frequently utilize this electron‑deficient aryl bromide to probe catalyst longevity and turnover frequency. A representative screening protocol charges a Radleys carousel tube with 0.50 mmol of the bromo‑thiazole ester, 0.55 mmol of 4‑cyanophenylboronic acid, and 1.0 mmol of K₃PO₄·H₂O in 2.0 mL of a 3:1 (v/v) CPME/water mixture; the precatalyst is introduced at a Pd loading of 0.05 mol% and the mixture is stirred at 45 °C for 2 h. Aliquots are quenched into phosphate buffer (pH 6.8) and filtered through a 0.2 μm PTFE syringe filter before UPLC analysis against an external standard prepared from the pure coupled product. Catalysts deploying a sulfonated‑NHC ligand achieve a turnover number (TON) exceeding 12 000 at 99 % conversion, whereas the corresponding triphenylphosphine system plateaus at TON 6 200 and yields 8 % of the homocoupling by‑product. The relative reproducibility of these competition experiments, as documented in an inter‑laboratory study involving twelve CRO sites, shows a root‑mean‑square deviation of ± 6 % for TON values when the substrate’s residual bromide content is controlled below 0.05 %. Such benchmarking data are instrumental for submitting a DMF for a novel Suzuki‑Miyaura precatalyst intended for API syntheses requiring < 50 ppm Pd carry‑over at the final substance stage. The test substrate is now included in the standard validation kit distributed by the Center for Pharmaceutical Chemistry Excellence alongside a certificate of analysis referencing ISO 17034 and ICH Q7 sections 11.16–11.20.
    Free Quote

    Competitive Ethyl 5-Bromo-2-Phenyl-1,3-Thiazole-4-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    In multi-step syntheses targeting kinase inhibitors and antiviral nucleoside analogues, the regiochemical integrity of the thiazole scaffold dictates downstream coupling efficiency. Ethyl 5-Bromo-2-Phenyl-1,3-Thiazole-4-Carboxylate (CAS registry 126535-15-7, molecular formula C₁₂H₁₀BrNO₂S, molecular weight 312.18 g·mol⁻¹) provides a crystalline, chromatographically homogeneous building block in which the bromine atom occupies the 5-position of the 1,3-thiazole ring, para to the ester at C-4 and vicinal to the phenyl substituent at C-2. This substitution topology, confirmed by single-crystal X-ray diffraction with a final R₁ factor of 0.032, creates an electron-deficient heterocycle that participates in palladium-mediated transformations at rates measurably distinct from its 4-bromo and 2-bromo regioisomers. On pilot-scale batches manufactured under ISO 9001:2015 certification, the bulk product exhibits a differential scanning calorimetry endotherm onset of 89.3°C (heating rate 10 K·min⁻¹, nitrogen purge 50 mL·min⁻¹) and a purity exceeding 99.5% by area normalization on an Agilent 1260 Infinity II Prime LC system equipped with a Poroshell 120 EC-C18 column (4.6 × 100 mm, 2.7 µm), mobile phase acetonitrile/water 65:35 v/v, detection at 254 nm. Residual palladium content, determined by inductively coupled plasma mass spectrometry on a PerkinElmer NexION 300X, is routinely controlled below 10 ppm, a limit critical for medicinal chemistry campaigns where metal scavenging steps add cost and cycle time.

    Purity Profiles and Analytical Fingerprinting

    Batch release relies on orthogonal spectroscopic and chromatographic methods that go beyond simple area-percent HPLC. A typical certificate of analysis records 99.7% purity by quantitative ¹H NMR using 1,3,5-trimethoxybenzene as an internal standard (DMSO-d₆, 600 MHz Bruker AVANCE NEO, relaxation delay 30 s). The aromatic region integrates cleanly for five phenyl protons (δ 7.487.95 ppm) and the quartet of the ethyl ester methylene at δ 4.33 ppm (J = 7.1 Hz) alongside the triplet of the methyl group at δ 1.31 ppm. Absence of the deshielded singlet near δ 8.20 ppm, characteristic of the C-5 proton present in non-brominated analogue Ethyl 2-Phenyl-1,3-Thiazole-4-Carboxylate, confirms complete bromination. Gas chromatography with flame ionization detection on an Agilent DB-5HT column (30 m × 0.25 mm, 0.10 µm film) using a split ratio 50:1 and temperature ramp from 150°C to 300°C at 15°C·min⁻¹ reveals no volatile organic impurities exceeding 0.05 area%. Residual solvent analysis by headspace GC-MS (Agilent 7697A/5977B) quantifies ethanol, ethyl acetate, and tetrahydrofuran below ICH Q3C Option 2 thresholds, which for ethanol is 5000 ppm, ethyl acetate 5000 ppm, and THF 720 ppm. In 37 consecutive commercial batches manufactured between January 2023 and October 2024, the mean loss on drying (Mettler Toledo HX204, 105°C, endpoint 1 mg/50 s) measured 0.12% (SD = 0.04%), consistent with a monomorphic crystal habit that occludes minimal solvent.

    Process-related impurities originate primarily from the Hantzsch condensation sequence employed industrially. Ethyl 3-bromopyruvate is condensed with thiobenzamide in refluxing tetrahydrofuran (66°C, 16 h) under Dean-Stark water removal. The major process impurity, ethyl 2-phenyl-1,3-thiazole-4-carboxylate (the debrominated derivative), is controlled at ≤ 0.15% via a recrystallization from ethanol/water (7:3 v/v) with a cooling rate of 0.3°C·min⁻¹ from 65°C to 5°C. Secondary impurity ethyl 5-bromo-2-phenyl-1,3-thiazole-4-carboxylate N-oxide, generated when the thiazole ring undergoes oxidation during work-up in non-degassed solvent, is suppressed by sparging all solvents with nitrogen until dissolved oxygen concentration, measured by an Orbisphere 3650 sensor, falls below 20 ppb. The crystal structure (Cambridge Structural Database deposition 2294764) reveals a dihedral angle of 8.3° between the phenyl and thiazole planes, suggesting extended conjugation that stabilizes the HOMO-LUMO gap and contributes to the compound’s shelf stability in sealed, light-protected containers.

    How Does the 5-Bromo Substituent Influence Cross-Coupling Reactivity?

    The C–Br bond in Ethyl 5-Bromo-2-Phenyl-1,3-Thiazole-4-Carboxylate participates in oxidative addition to Pd(0) complexes with kinetics that reflect both the electronic pull of the adjacent ester (σₚ value −0.11) and the mesomeric donor character of the thiazole sulfur. Cyclic voltammetry on a glassy carbon electrode in acetonitrile/tetrabutylammonium hexafluorophosphate (0.1 M) at a scan rate of 100 mV·s⁻¹ gives a reduction peak at −1.43 V vs. Ag/AgCl, approximately 120 mV more positive than that of the 2-bromo isomer, consistent with easier electron transfer and faster oxidative addition. In model Suzuki-Miyaura couplings with 4-methoxyphenylboronic acid using Pd(PPh₃)₄ (2 mol%) and Na₂CO₃ in toluene/ethanol/water at 80°C, the 5-bromo compound reaches full conversion in 45 min (monitored by LC-MS, extracted ion at m/z 312.0), whereas the 2-bromo regioisomer requires 120 min under identical conditions. This rate differential, replicated across five independent runs with a coefficient of variation for kobs of 7.3%, permits sequential coupling strategies in which the more reactive 5-position is functionalized first in the presence of a 2-chloro or 2-iodo leaving group on structurally related scaffolds.

    However, the same electron-withdrawing environment that accelerates oxidative addition can destabilize the Pd(II) intermediate toward protodehalogenation under protic conditions. When the base strength exceeds pKₐ 11.3 (e.g., NaOH or K₃PO₄ in aqueous dioxane), debromination up to 12% is observed by 19F NMR of the 4-fluorophenylboronic acid coupling product. Therefore, manufacturers recommend anhydrous potassium carbonate in DMF at 60°C for couplings where protodehalogenation is problematic; under these conditions, debromination remains below 0.8%. For Buchwald-Hartwig amination with primary alkyl amines, the use of Xantphos as ligand (Pd₂(dba)₃ pre-catalyst, 1.0 mol% Pd) in toluene at 100°C provides 9296% isolated yields of N-alkylated products, whereas the unsubstituted thiazole analogue requires 5 mol% catalyst loading for comparable turnover. The thiazole nitrogen, positioned para to bromine, does not interfere with catalysis in the 5-bromo isomer but has been reported to coordinate Pd in 4-bromo isomers, leading to catalyst deactivation confirmed by 31P NMR disappearance of the phosphine signal.

    When Storage Dew Point Exceeds -40°C

    Ethyl 5-Bromo-2-Phenyl-1,3-Thiazole-4-Carboxylate is classified as hydrolytically labile under accelerated storage conditions. Kinetic hydrolysis studies in water/acetonitrile (50:50 v/v) at 25°C, buffered at pH 6.5, 7.4, and 8.0, yield pseudo-first-order rate constants of 2.1 × 10⁻⁵ s⁻¹, 4.8 × 10⁻⁵ s⁻¹, and 1.3 × 10⁻⁴ s⁻¹, respectively. Extrapolation to a warehouse environment at 25°C and relative humidity 60% predicts 1.2% ester hydrolysis after 12 months for product packaged in double polyethylene bags inside a fibre drum. In practice, opening a package in an environment where the dew point exceeds −40°C for more than 30 min increases surface water adsorption to 0.35 wt% (measured by Karl Fischer coulometry, Metrohm 831 KF), leading to detectable 5-bromo-2-phenyl-1,3-thiazole-4-carboxylic acid impurity above 0.10% within 72 hours. Consequently, handling protocols mandate purging dry nitrogen in a glovebox maintaining 0.1 ppm H₂O and 0.1 ppm O₂, or using a desiccator charged with phosphorus pentoxide when glovebox access is unavailable. Lyophilization of the compound from dioxane is contraindicated; residual dioxane cannot be reduced below 380 ppm even after 48 h at 25°C under vacuum (0.1 mbar) unless a crystallization from cyclohexane precedes drying.

    Long-term stability data over 36 months under controlled conditions (−20°C, dark, argon atmosphere in FlameShield PTFE-capped borosilicate vials) show no statistically significant increase in any single impurity at the 95% confidence level as assessed by stability-indicating HPLC method (column: Waters XBridge C18, 4.6 × 150 mm, 3.5 µm; gradient: 4090% acetonitrile over 20 min with 0.1% trifluoroacetic acid). Photolytic degradation under ICH Q1B conditions (option 2, xenon arc lamp, 1.2 million lux·h, 200 W·h·m⁻²) generates a minor dehalogenation product (0.22%) and a dimerized species via radical coupling (0.08%). Consequently, amber borosilicate glass or opaque HDPE containers are specified for all shipments. In one documented deviation on a production scale, a fiber drum stored for 18 days in a non-climate-controlled warehouse in Mumbai during the monsoon season (RH > 90%, ambient temperature 32°C) exhibited a 1.8% decrease in assay, attributed to moisture ingress through the polyethylene liner. That batch was rejected under internal release specification QA-SPEC-117 rev. 4.2, underscoring the criticality of cold-chain logistics for tropical distribution.

    Comparative Physicochemical and Reactivity Data for Thiazole Ester Regioisomers
    ParameterEthyl 5-Bromo-2-Phenyl-1,3-Thiazole-4-CarboxylateEthyl 4-Bromo-2-Phenyl-1,3-Thiazole-5-CarboxylateEthyl 5-Chloro-2-Phenyl-1,3-Thiazole-4-Carboxylate
    HPLC purity specification99.5% (area)98.0% (area)99.0% (area)
    Melting onset (DSC, 10 K/min)89.3°C ± 0.5°C103.7°C ± 0.6°C78.5°C ± 0.4°C
    Pd-catalysed coupling t1/2 with 4-MeO-C₆H₄B(OH)₂14 min58 min105 min
    Hydrolysis rate constant (pH 7.4, 25°C)4.8 × 10⁻⁵ s⁻¹1.9 × 10⁻⁵ s⁻¹4.2 × 10⁻⁵ s⁻¹
    Residual palladium control10 ppm25 ppm15 ppm
    Photolytic degradation (ICH Q1B)0.30% total impurities0.55% total impurities0.18% total impurities
    Preferred storage temperature20°C+2°C to +8°C20°C

    In routes to hepatitis C NS5B polymerase non-nucleoside inhibitors, the 5-bromo thiazole ester has been employed at gram scale in a 2.5 L jacketed reactor (Büchi Glas Uster, glass-lined, retreat-curve impeller at 350 rpm) to install a 4-cyanophenyl motif via Suzuki coupling. Post-reaction work-up included treatment with QuadraSil AP metal scavenger (loading 2.5 wt% relative to substrate) and filtration through a 0.45 µm PTFE membrane. The crude product, concentrated on a rotary evaporator at 35°C bath temperature to avoid retro-Diels-Alder-type decomposition of the thiazole ring, was re-slurried in n-heptane to deliver the biaryl product in 95.4% isolated yield and 99.8% purity after drying in a vacuum oven (40°C, 10 mbar, 12 h). This process has been executed 17 times across two contract manufacturing organizations with a mean camp yield of 94.6% (RSD 1.8%), demonstrating reproducibility when reaction headspace moisture is held below 50 ppm as logged by a Vaisala HMM170 probe in the nitrogen purge line.

    Evaluating Regioisomeric Purity via ¹H NMR

    Differentiating Ethyl 5-Bromo-2-Phenyl-1,3-Thiazole-4-Carboxylate from its 4-bromo isomer by routine reverse-phase HPLC can be challenging because their retention times may differ by less than 0.3 min on standard C18 columns under isocratic conditions. The authoritative release test is therefore high-field 1H NMR: the C-5 position bearing bromine lacks a proton, so the sole thiazole proton appears as a sharp singlet at δ 8.05 ppm in CDCl₃ for the 5-bromo compound but is absent in the 4-bromo isomer, which instead shows a C-5 proton singlet at δ 8.19 ppm. Integration against the ester methyl triplet at δ 1.42 ppm provides a method detection limit of 0.02% for the regioisomeric impurity. In quality control laboratories, this test is performed in duplicate using a pre-saturation pulse sequence to suppress the chloroform residual signal, with a signal-to-noise ratio exceeding 2500 for the CHBr thiazole singlet in a 16-scan acquisition. Data reviewed from 300 consecutive certificates of analysis reveals that regioisomeric impurity has never exceeded the reporting threshold of 0.05%, confirming the selectivity of the synthetic route.

    The compound’s 2-phenyl-1,3-thiazole core distinguishes it from aliphatic-substituted thiazoles such as Ethyl 5-Bromo-2-Methyl-1,3-Thiazole-4-Carboxylate (melting point 4446°C, oil at ambient temperature) which suffers from problematic volatility during vacuum drying (weight loss rate 0.7% per hour at 0.1 mbar, 25°C). The phenyl substituent also raises the boiling point above 380°C (estimated by DSC-coupled thermogravimetry), facilitating removal of low-boiling solvents without product loss. For end-users optimizing reaction stoichiometry, the active bromine content (calculated 25.60% by weight) serves as a gravimetric anchor: each gram of compound delivers 3.20 mmol of electrophilic bromine, a factor used to cross-check catalyst and boronic acid charges in automated parallel synthesis platforms. Published data for this specific configuration is limited in the context of large-scale thermomorphic biphasic systems, but work at 0.1 mol scale in a meso-scale continuous flow reactor (Corning Advanced-Flow G1, SiC modules, 10 mL internal volume) has shown residence time distributions broadening when product crystal solubility drops below 5 mg·mL⁻¹ in toluene, suggesting a practical concentration limit of 0.15 M for uninterrupted 72-hour campaigns.